Genetic epidemiology of COPD

Chest

Volumn 121, Issue 3, 2002, Pages 1S-6S

  Silverman, Edwin K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; FATTY ACID BINDING PROTEIN; LEUKOCYTE ELASTASE; PROTEINASE; PROTEINASE INHIBITOR;

AIRWAY OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONFERENCE PAPER; EMPHYSEMA; ENZYME ACTIVITY; FORCED EXPIRATORY VOLUME; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; HEREDITY; HUMAN; LUNG FUNCTION; NULL ALLELE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN SYNTHESIS;

EID: 0036130113     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.3_suppl.1S-a     Document Type: Conference Paper

References (43)

1. Quantitative relationships between cigarette smoking and ventilatory function
2. Elastases and emphysema: Current assessment of the protease-antiprotease hypothesis
3. Alpha 1-antitrypsin Pi-types in 965 COPD patients
4. Human plasma proteinase inhibitors
5. Molecular basis of alpha-1-antitrypsin deficiency
6. Genetics and respiratory disease: 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema
7. Natural history and life expectancy in severe alpha 1-antitrypsin deficiency, Pi Z
8. Alpha 1-antitrypsin deficiency: The clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z
9. Smoking, lung function, and alpha 1-antitrypsin deficiency
10. Variability of pulmonary function in alpha 1-antitrypsin deficiency: Clinical correlates
11. Family study of alpha 1-antitrypsin deficiency: Effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits
12. Chronic obstructive pulmonary disease: A challenge in genetic epidemiology
13. Sweat chloride and delta F508 mutation in chronic bronchitis or bronchiectasis
14. Mis-sense mutation of alpha 1-antichymotrypsin gene associated with chronic lung disease
15. Independent mutations in the flanking sequence of the alpha-1-antitrypsin gene are associated with chronic obstructive airways disease
16. Vitamin D binding protein variants and the risk of COPD
17. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema
18. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease
19. Alpha 1-antichymo-trypsin mutations in patients with chronic obstructive pulmonary disease
20. Mutation in the 3′ region of the alpha-1-antitrypsin gene and chronic obstructive pulmonary disease
21. Genetic markers for chronic bronchitis and peak expiratory flow in the Copenhagen Male study
22. Common CFTR mutations are not likely to predispose to chronic bronchitis in northern Germany
23. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: Combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1
24. Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease
25. Case-control association studies for the genetics of complex respiratory diseases
26. Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins
27. Risk factors in chronic obstructive pulmonary disease (COPD)
28. Genetic and environmental determinants of chronic obstructive pulmonary disease
29. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study
30. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease: Risk to relatives for airflow obstruction and chronic bronchitis
31. Bronchodilator responsiveness and serum total IgE levels in families of probands with severe early-onset COPD
32. Breathlessness in patients with severe chronic airflow limitation: Physiologic correlations
33. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD
34. Prognosis in severe chronic obstructive pulmonary disease
35. Prognosis in severe chronic obstructive pulmonary disease
36. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease
37. Linkage analysis of alpha 1-antitrypsin deficiency: Lessons for complex diseases
38. Parametric and nonparametric linkage analysis: A unified multipoint approach
39. Multipoint oligogenic linkage analysis of quantitative traits
40. Linkage between quantitative trait and marker loci: Methods using all relative pairs
41. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
42. Genetic markers in chronic air-flow limitation: A genetic epidemiologic study